From: Survival of patients with rare diseases: a population-based study in Tuscany (Italy)
 | Sex | Age at diagnosis | Period of diagnosis | |||
---|---|---|---|---|---|---|
HRb | 95% CI | HRc | 95% CI | HRd | 95% CI | |
Metabolic diseases | Â | Â | Â | Â | Â | Â |
Disorders of mitochondrial metabolism | 3.12 | 0.99–9.80 | 1.05 | 1.02–1.09 | 0.67 | 0.20–2.25 |
Lysosomal storage diseases | 1.21 | 0.56–2.61 | 0.99 | 0.96–1.01 | 1.04 | 0.39–2.79 |
Disorders of vitamin and non-protein cofactor absorption and transport | 5.87 | 0.96–35.98 | 1.05 | 1.00–1.11 | 0.17 | 0.02–1.54 |
Disorders of metal metabolism and transport | 3.14 | 0.96–10.30 | 1.09 | 1.03–1.15 | 0.87 | 0.31–2.43 |
Disorders of protein metabolism and transport | 0.72 | 0.049–1.04 | 1.05 | 1.04–1.07 | 0.96 | 0.61–1.50 |
Other metabolic diseasesa | 2.04 | 0.81–1.17 | 1.04 | 1.03–1.07 | 0.70 | 0.26–0.94 |